• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Obesity drug mania takes over Amgen’s earnings call

cafead

Administrator
Staff member
  • cafead   Feb 07, 2024 at 09:22: PM
via Analysts pressed company executives Tuesday on the potential of its GLP-1 drug for weight loss, early-stage results for which were published earlier this week.

article source